Cystic fibrosis future or investigational therapies: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
Line 18: Line 18:
{{reflist|2}}
{{reflist|2}}


[[Category:Needs content]]
[[Category:Medicine]]
[[Category:Channelopathy]]
[[Category:Up-To-Date]]
[[Category:Genetic disorders]]
[[Category:Autosomal recessive disorders]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Pediatrics]]
[[Category:Pediatrics]]
[[Category:Pulmonology]]
[[Category:Pulmonology]]
[[Category:Mature chapter]]
[[Category:Disease]]

Latest revision as of 21:03, 9 March 2018


Cystic fibrosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cystic fibrosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography or Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cystic fibrosis future or investigational therapies On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cystic fibrosis future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cystic fibrosis future or investigational therapies

CDC on Cystic fibrosis future or investigational therapies

Cystic fibrosis future or investigational therapies in the news

Blogs on Cystic fibrosis future or investigational therapies

Directions to Hospitals Treating Cystic fibrosis

Risk calculators and risk factors for Cystic fibrosis future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]

Overview

In cystic fibrosis therapies under investigation include prophylactic ursodiol therapy; CF corrector VX-661; inhaled dry powder mannitol and CFTR gene therapy.

future or investigational therapies

In cystic fibrosis therapies under investigation include:[1]

References

  1. "Cystic Fibrosis and Congenital Absence of the Vas Deferens - GeneReviews® - NCBI Bookshelf".